Two years after rules overhaul, have methadone clinics really changed? — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- SAMHSA's 2024 methadone clinic overhaul is showing measurable adoption, with AATOD and NAATP survey data indicating more than 70% of responding clinics adopted at least half of the recommended practice changes, including expanded take-home medication access and higher starting doses.
- Mark Parrino, president of AATOD, said more than 75% of opioid treatment programs have provided more take-home medication, and that treatment retention has significantly increased as a result.
- Dustin Mets, CEO of Ohio-based CompDrug, reported the share of patients still in treatment three months after first seeking care increased an average of 17% following implementation of the changes.
- Roughly two-thirds of state opioid treatment authorities have adopted the practice of offering and encouraging counseling without threatening to withhold medication from patients who decline.
- SAMHSA eliminated two long-standing restrictions: one requiring patients to have been addicted to opioids for over a year, and another requiring patients to have failed other treatments twice before methadone clinic admission.
- Aaron Ferguson of the Liberate Methadone movement disputed the industry's rosy framing, arguing the survey of just 241 clinics — about 10% of OTPs nationwide — suffers from selection bias and that large providers in more conservative states have largely ignored the changes.
Why it matters: For patients receiving methadone, the post-2024 shift ends decades of punitive daily attendance requirements and opens access to take-home dosing, but the survey's thin response rate (10% of clinics) and acknowledged geographic disparities mean the actual national picture remains unclear, with critics warning progress is concentrated among already-progressive providers.
Ask SkimNews
